ATTEST 2
The ATTEST 2 trial compared how effective the clot busting drugs, tenecteplase and alteplase, are at improving recovery after a stroke.
Impact of clinical trials: stroke
BHF-funded clinical trials have helped to advance treatment and prevention of stroke.
Our completed trials
LACI 2
LACI 2 explored whether 2 existing drugs could be used to treat lacunar stroke. This type of stroke can lead to dementia.
OPTIMAS
OPTIMAS tested how soon anti clotting drugs should be started after a stroke in people with atrial fibrillation.
RESTART
This trial tested whether it is safe to restart antiplatelet drugs, such as aspirin, after a brain haemorrhage.
STASH
A subarachnoid haemorrhage (SAH) is a type of stroke caused by bleeding on the brain’s surface. STASH tested if statins could boost recovery from SAH.
TWIST
This study examined whether people who wake up with a stroke should be treated with clot busting medicine.
XILO FIST
Allopurinol is commonly used to treat gout. XILO FIST looked at whether this medication can also treat a stroke or transient ischaemic attack.